Nuvectis Pharma, Inc. (NVCT) Tops Q3 EPS by 1c

Nuvectis Pharma, Inc. (NASDAQ: NVCT) reported Q3 EPS of ($0.24), $0.01 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Nuvectis Pharma, Inc. (NVCT) click here.

You May Also Be Interested In

• Evogene (EVGN) Tops Q2 EPS by 15c
• H.C. Wainwright Reiterates Neutral Rating on Aethlon Medical (AEMD)
• Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance